These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Phase I/II study of high-dose cyclophosphamide, etoposide and cisplatin followed by autologous bone marrow or peripheral blood stem cell transplantation in patients with poor prognosis Hodgkin's disease or non-Hodgkin's lymphoma. Klumpp TR; Mangan KF; Glenn LD; Malaspina DR; Cropper T; Mullaney M; Macdonald JS Bone Marrow Transplant; 1993 Oct; 12(4):337-45. PubMed ID: 7506091 [TBL] [Abstract][Full Text] [Related]
10. Phase I trial with pharmacokinetic analyses of high-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in patients with refractory germ cell tumors. Motzer RJ; Gulati SC; Tong WP; Menendez-Botet C; Lyn P; Mazumdar M; Vlamis V; Lin S; Bosl GJ Cancer Res; 1993 Aug; 53(16):3730-5. PubMed ID: 8393380 [TBL] [Abstract][Full Text] [Related]
12. Escalating high-dose carboplatin and autologous bone marrow transplantation in solid tumors. Pico JL; Ibrahim A; Castagna L; Bourhis JH; Chazard M; Maraninchi D; Droz JP Oncology; 1993 Nov; 50 Suppl 2():47-52. PubMed ID: 8233302 [TBL] [Abstract][Full Text] [Related]
13. High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term results. Bertucci F; Viens P; Delpero JR; Bardou VJ; Faucher C; Houvenaeghel G; Maraninchi D Bone Marrow Transplant; 2000 Jul; 26(1):61-7. PubMed ID: 10918406 [TBL] [Abstract][Full Text] [Related]
14. [Combination of high-dose chemotherapy with autologous hematopoietic stem cell transplantation for recurrent and high-risk breast cancer: a pilot study]. Shi Y; Pan F; Han X Zhonghua Yi Xue Za Zhi; 1999 Dec; 79(12):890-3. PubMed ID: 11715500 [TBL] [Abstract][Full Text] [Related]
15. Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors. Motzer RJ; Mazumdar M; Gulati SC; Bajorin DF; Lyn P; Vlamis V; Bosl GJ J Natl Cancer Inst; 1993 Nov; 85(22):1828-35. PubMed ID: 7693955 [TBL] [Abstract][Full Text] [Related]
16. Sequential cycles of high-dose chemotherapy with dose escalation of carboplatin with or without paclitaxel supported by G-CSF mobilized peripheral blood progenitor cells: a phase I/II study in advanced ovarian cancer. Wandt H; Birkmann J; Denzel T; Schäfer K; Schwab G; Pilz D; Egger H; Both A; Gallmeier WM Bone Marrow Transplant; 1999 Apr; 23(8):763-70. PubMed ID: 10231137 [TBL] [Abstract][Full Text] [Related]
17. A phase II study of two cycles of high-dose chemotherapy with autologous stem cell support in patients with metastatic breast cancer who meet eligibility criteria for a single cycle. Bashey A; Corringham S; Garrett J; Lane TA; Gilpin EA; Corringham RE; Law P; Ho AD Bone Marrow Transplant; 2000 Mar; 25(5):519-24. PubMed ID: 10713629 [TBL] [Abstract][Full Text] [Related]
18. Phase II trial of ifosfamide and cisplatinum in advanced ovarian cancer. Aziz Z; Zahid M; Ud Din Ahmed Z; Arshad T Aust N Z J Med; 1998 Jun; 28(3):403-9. PubMed ID: 9673759 [TBL] [Abstract][Full Text] [Related]
19. Intensive sequential chemotherapy with repeated blood stem-cell support for untreated poor-prognosis non-Hodgkin's lymphoma. Stoppa AM; Bouabdallah R; Chabannon C; Novakovitch G; Vey N; Camerlo J; Blaise D; Xerri L; Resbeut M; Di Stefano D; Bardou VJ; Gastaut JA; Maraninchi D J Clin Oncol; 1997 May; 15(5):1722-9. PubMed ID: 9164178 [TBL] [Abstract][Full Text] [Related]
20. Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer. Brugger W; Frommhold H; Pressler K; Mertelsmann R; Kanz L Semin Oncol; 1995 Feb; 22(1 Suppl 2):3-8. PubMed ID: 7531368 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]